SI-BONE Inc (SIBN)
14.19
-0.42
(-2.87%)
USD |
NASDAQ |
May 03, 16:00
14.19
0.00 (0.00%)
After-Hours: 20:00
SI-BONE SG&A Expense (Quarterly): 37.02M for Dec. 31, 2023
SG&A Expense (Quarterly) Chart
Historical SG&A Expense (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 37.02M |
September 30, 2023 | 34.22M |
June 30, 2023 | 35.29M |
March 31, 2023 | 34.79M |
December 31, 2022 | 34.68M |
September 30, 2022 | 32.74M |
June 30, 2022 | 36.52M |
March 31, 2022 | 32.74M |
December 31, 2021 | 32.74M |
September 30, 2021 | 29.72M |
June 30, 2021 | 29.64M |
March 31, 2021 | 26.86M |
December 31, 2020 | 25.31M |
Date | Value |
---|---|
September 30, 2020 | 23.69M |
June 30, 2020 | 19.91M |
March 31, 2020 | 24.68M |
December 31, 2019 | 24.47M |
September 30, 2019 | 23.26M |
June 30, 2019 | 20.92M |
March 31, 2019 | 20.58M |
December 31, 2018 | 17.05M |
September 30, 2018 | 13.83M |
June 30, 2018 | 12.88M |
March 31, 2018 | 13.38M |
December 31, 2017 | 12.91M |
September 30, 2017 | 13.93M |
SG&A Expense Definition
SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.
SG&A Expense (Quarterly) Range, Past 5 Years
19.91M
Minimum
Jun 2020
37.02M
Maximum
Dec 2023
29.43M
Average
29.72M
Median
Sep 2021
SG&A Expense (Quarterly) Benchmarks
Conmed Corp | 123.36M |
TransMedics Group Inc | 36.16M |
Inari Medical Inc | 103.06M |
Electromed Inc | 8.175M |
Myomo Inc | 4.66M |